Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dong Xi

Showing results (111-120 of 179) with videos related to

Pageof 18
Sort By:
Human Gene Therapy|March 12, 2010
Dual interference with novel genes mfgl2 and mTNFR1 ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ miceSui Gao, Ming Wang, Huali Ye, et al.
Heliyon|April 9, 2024
The efficacy of antiviral treatment in chronic hepatitis B patients with hepatic steatosisDanqing Hu, Peng Wang, Xiaojing Wang, et al.
Frontiers in Immunology|January 9, 2019
Clara Cell 10 kDa Protein Alleviates Murine Hepatitis Virus Strain 3-Induced Fulminant Hepatitis by Inhibiting Fibrinogen-Like Protein 2 ExpressionHaijing Yu, Yang Liu, Hongwu Wang, et al.
The Journal of Gene Medicine|May 15, 2018
Soluble Fgl2 restricts autoimmune hepatitis progression via suppressing Tc17 and conventional CD8+ T cell functionGuo Ai, Weiming Yan, Haijing Yu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 14, 2023
Disease severity and antiviral response in patients with chronic hepatitis B with non-obese NAFLDDanqing Hu, Peng Wang, Xiaojing Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 4, 2011
[Two novel mutations in one pedigree with hereditary Factor VII deficiency]Zhi-fang Xing, Xue-feng Wang, Jing Dai, et al.
International Journal of Clinical and Experimental Medicine|July 30, 2015
Multimodal imaging and clinical characteristics of bone lesions in POEMS syndromeXiao-Feng Shi, Shu-Dong Hu, Jun-Min Li, et al.
Statistics in Biopharmaceutical Research|June 30, 2021
Challenges in Assessing the Impact of the COVID-19 Pandemic on the Integrity and Interpretability of Clinical TrialsMouna Akacha, Janice Branson, Frank Bretz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 29, 2012
Downregulation of FGL2/prothrombinase delays HCCLM6 xenograft tumour growth and decreases tumour angiogenesisYanling Liu, Li Xu, Qili Zeng, et al.
World Journal of Gastroenterology|October 22, 2008
Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gammaKai Su, Fang Chen, Wei-Ming Yan, et al.
Pageof 18

Showing results (111-120 of 179) with videos related to

Sort By:
Pageof 18
Human Gene Therapy|March 12, 2010
Dual interference with novel genes mfgl2 and mTNFR1 ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ miceSui Gao, Ming Wang, Huali Ye, et al.
Heliyon|April 9, 2024
The efficacy of antiviral treatment in chronic hepatitis B patients with hepatic steatosisDanqing Hu, Peng Wang, Xiaojing Wang, et al.
Frontiers in Immunology|January 9, 2019
Clara Cell 10 kDa Protein Alleviates Murine Hepatitis Virus Strain 3-Induced Fulminant Hepatitis by Inhibiting Fibrinogen-Like Protein 2 ExpressionHaijing Yu, Yang Liu, Hongwu Wang, et al.
The Journal of Gene Medicine|May 15, 2018
Soluble Fgl2 restricts autoimmune hepatitis progression via suppressing Tc17 and conventional CD8+ T cell functionGuo Ai, Weiming Yan, Haijing Yu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 14, 2023
Disease severity and antiviral response in patients with chronic hepatitis B with non-obese NAFLDDanqing Hu, Peng Wang, Xiaojing Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 4, 2011
[Two novel mutations in one pedigree with hereditary Factor VII deficiency]Zhi-fang Xing, Xue-feng Wang, Jing Dai, et al.
International Journal of Clinical and Experimental Medicine|July 30, 2015
Multimodal imaging and clinical characteristics of bone lesions in POEMS syndromeXiao-Feng Shi, Shu-Dong Hu, Jun-Min Li, et al.
Statistics in Biopharmaceutical Research|June 30, 2021
Challenges in Assessing the Impact of the COVID-19 Pandemic on the Integrity and Interpretability of Clinical TrialsMouna Akacha, Janice Branson, Frank Bretz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 29, 2012
Downregulation of FGL2/prothrombinase delays HCCLM6 xenograft tumour growth and decreases tumour angiogenesisYanling Liu, Li Xu, Qili Zeng, et al.
World Journal of Gastroenterology|October 22, 2008
Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gammaKai Su, Fang Chen, Wei-Ming Yan, et al.
Pageof 18